Impossible to document adverse effects of calcium antagonists. Effects equal to those of conservative treatment of hypertension
Nilsson, P.
Lakartidningen 97(35): 3710-3712
2000
ISSN/ISBN: 0023-7205 PMID: 11016222 Document Number: 517219
Document emailed within 1 workday
Related Documents
Lin, M.S.; Huang, C.S.; Leen, D.Y. 1988: Lack of effects of calcium antagonists on red blood cell deformability in hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 26(12): 585-587Shiotani, M.; Arita, M.; Nakatsu, C.; Nakamura, N.; Ohshika, H.; Nakamura, Y.; Fujiwara, S.; Ueno, Y.; Nishio, I.; Masuyama, Y. 1990: Effects of calcium antagonists or beta-blockade on left ventricular diastolic function in essential hypertension Journal of Cardiology 20(1): 135-145
Raddino, R.; Poli, E.; Pelà, G.; Ferrari, A.; Ghirarduzzi, A.; Ferrari, R. 1987: Effects of calcium antagonists on intracellular calcium deposits Cardiologia 32(4): 395-399
Schoenberger, J.A. 1988: Calcium antagonists: use in hypertension evaluation of calcium antagonists in combination with diuretics Angiology 39(1 Part 2): 87-93
Yagil, Y.; Yagil, C. 1983: Calcium antagonists in the treatment of hypertension Harefuah 104(7): 313-314
Krzesinski, J.M.; Rorive, G.L. 1988: Calcium antagonists in the treatment of arterial hypertension Revue Medicale de Liege 43(9): 310-320
Klaus, D. 1992: The role of calcium antagonists in the treatment of hypertension Journal of Cardiovascular Pharmacology 20(Suppl 6): S5-14
Rosenthal, J.; Völger, K.D. 1991: The role of calcium antagonists in the treatment of hypertension Der Internist 32(12): 674-689
Andreeva, T.N. 1990: Foridone and other calcium antagonists in the treatment of essential hypertension Cor et Vasa 32(1): 45-55
Lederballe Pedersen, O. 1983: The experimental use of calcium antagonists in the treatment of arterial hypertension Postgraduate Medical Journal 59(Suppl 2): 84-90
Ito, H.; Nakahara, K.; Sato, M.; Takada, N.; Hirakawa, S. 1983: Effects of calcium antagonists on mean circulatory pressure Nihon Rinsho. Japanese Journal of Clinical Medicine 41(12): 2709-2720
Furlanello, F.; Disertori, M.; Vergara, G.; Molinis, G.; Guarnerio, M.; Stefenelli, C. 1978: Electrophysiological effects of calcium-antagonists and their use in arrhythmia Bollettino Della Societa Italiana di Cardiologia 1978(1 Suppl): 60-78
Thuillez, C.; Giudicelli, J.F. 1981: Cardiovascular effects of calcium antagonists drug Therapie 36(2): 107-121
Fleckenstein-Grün, G.; Frey, M.; Thimm, F.; Fleckenstein, A. 1992: Protective effects of various calcium antagonists against experimental arteriosclerosis Journal of Human Hypertension 6(Suppl 1): S13-S18
Pastore, L.R.; Bartolo, M.; Penco, M.; Arata, L.; Di Renzi, L. 1979: Regional hemodynamic and metabolic effects of calcium antagonists Bollettino Della Societa Italiana di Cardiologia 24(8): 805-816
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Brandt, D. 1983: Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis Wiener Medizinische Wochenschrift 133(6): 131-135
Greven 1972: Relaxation effects on smooth muscles following administration of calcium antagonists Hippokrates 43(3): 363-364
Mildenberger, D.; Klepzig, H.; Hopf, R.; Kaltenbach, M. 1989: The spectrum of side effects of gallopamil in comparison with other calcium antagonists Zeitschrift für Kardiologie 78(Suppl 5): 25-28